```html

Hyperglycemia (High Blood Sugar) – Comprehensive Medical Guide

Overview

Hyperglycemia refers to an abnormally high concentration of glucose in the bloodstream. In most adults, a fasting plasma glucose level ≥ 126 mg/dL (7.0 mmol/L) or a random glucose level ≥ 200 mg/dL (11.1 mmol/L) together with classic symptoms qualifies as hyperglycemia. While occasional spikes may occur after a large meal, persistent high blood sugar is a hallmark of diabetes mellitus (type 1, type 2, gestational, or other specific types) and can also be seen in acute illness, certain medications, or endocrine disorders.

Who is affected? Worldwide, an estimated 537 million adults (≈ 10 % of the global population) live with diabetes, and the majority experience hyperglycemia at some point in their disease course. In the United States alone, 34.2 million people have diabetes, and up to 90 % of them will have episodes of hyperglycemia that require medical attention.<sup>[1]</sup>

Hyperglycemia is not limited to people with diagnosed diabetes; stress‑induced hyperglycemia can affect hospitalized patients without a prior diagnosis, occurring in up to 40 % of intensive‑care admissions.<sup>[2]</sup>

Symptoms

Symptoms develop when glucose levels rise above the kidneys' capacity to reabsorb it, leading to osmotic diuresis and cellular dehydration. The classic triad includes:

• Polyuria – frequent, large‑volume urination.
• Polydipsia – intense thirst.
• Polyphagia – increased hunger despite high glucose.

Additional signs and symptoms may include:

• Fatigue – cells cannot use glucose for energy.
• Blurred vision – fluid shifts change the shape of the lens.
• Headache – dehydration and electrolyte changes.
• Weight loss (especially in type 1 diabetes) – due to catabolism of fat and muscle.
• Recurrent infections – especially urinary tract and skin infections.
• Dry mouth and skin.
• Nausea or vomiting – may herald diabetic ketoacidosis (DKA) in type 1.
• Weakness or tingling in the hands/feet – early peripheral neuropathy.
• Sudden changes in mental status – confusion or lethargy in severe hyperglycemia.

Causes and Risk Factors

Hyperglycemia results from either insufficient insulin action (relative or absolute) or excess hepatic glucose production. Common causes include:

1. Diabetes mellitus

• Type 1 diabetes – autoimmune destruction of β‑cells → absolute insulin deficiency.
• Type 2 diabetes – insulin resistance combined with progressive β‑cell dysfunction.
• Gestational diabetes – transient insulin resistance during pregnancy.
• Other specific types – e.g., MODY, pancreatic disease, endocrinopathies.

2. Medications

• Glucocorticoids (prednisone, dexamethasone)
• Thiazide diuretics
• β‑agonists (albuterol)
• Protease inhibitors (HIV therapy)
• Antipsychotics (e.g., olanzapine, clozapine)

3. Acute illness or stress

Infections, trauma, surgery, myocardial infarction, or stroke increase counter‑regulatory hormones (cortisol, epinephrine, growth hormone) that raise glucose.

4. Endocrine disorders

• Cushing’s syndrome
• Acromegaly
• Pheochromocytoma

5. Lifestyle factors

• Excessive carbohydrate intake without adequate insulin or medication adjustment.
• Physical inactivity.
• Obesity – a major driver of insulin resistance.

Who is at higher risk?

• Family history of diabetes.
• Age ≥ 45 years (risk rises sharply after 55).
• Body mass index (BMI) ≥ 30 kg/m².
• Ethnic groups with higher prevalence (e.g., African‑American, Hispanic, Native American, South‑Asian).
• History of gestational diabetes or polycystic ovary syndrome (PCOS).
• Chronic use of glucocorticoids or other hyperglycemia‑inducing drugs.

Diagnosis

Diagnosis is based on laboratory glucose measurements, often accompanied by a review of symptoms and medical history.

Key Tests

• Fasting Plasma Glucose (FPG) – ≥ 126 mg/dL on two separate occasions.
• Random Plasma Glucose – ≥ 200 mg/dL with classic hyperglycemia symptoms.
• Oral Glucose Tolerance Test (OGTT) – 2‑hour plasma glucose ≥ 200 mg/dL after 75 g glucose load.
• HbA1c (Glycated Hemoglobin) – ≥ 6.5 % reflects average glucose over 2‑3 months; useful for chronic monitoring.
• Continuous Glucose Monitoring (CGM) – provides real‑time trend data, increasingly used in both type 1 and type 2 patients.

In hospitalized patients, point‑of‑care capillary glucose checks are performed before meals and at bedtime. Persistent readings > 180 mg/dL (10 mmol/L) usually trigger therapeutic adjustments.

Treatment Options

Management aims to lower glucose to target ranges, prevent acute complications, and reduce long‑term vascular risk.

1. Medications

• Insulin therapy – rapid‑acting, short‑acting, intermediate, or long‑acting formulations; basal‑bolus regimens for type 1 and many type 2 patients.
• Oral antihyperglycemic agents (type 2):
  • Metformin – first‑line, reduces hepatic glucose production.
  • SGLT2 inhibitors – increase urinary glucose excretion (e.g., empagliflozin).
  • GLP‑1 receptor agonists – enhance insulin secretion, suppress appetite.
  • DPP‑4 inhibitors, sulfonylureas, thiazolidinediones – other options based on patient profile.
• Correctional insulin – short‑acting “sliding scale” or weight‑based dosing to treat acute spikes (e.g., 0.1 U/kg for glucose > 250 mg/dL).

2. Procedural Interventions

• Pancreas or islet cell transplantation – reserved for select refractory type 1 patients.
• Metabolic surgery (bariatric) – can induce remission of type 2 diabetes in obese individuals.

3. Lifestyle Modifications

• Medical nutrition therapy – carbohydrate counting, low‑glycemic-index foods, portion control.
• Physical activity – at least 150 minutes/week of moderate‑intensity aerobic exercise plus resistance training 2‑3 times/week.
• Weight management – aim for ≥ 5‑10 % weight loss if BMI ≥ 25 kg/m².
• Stress reduction – mindfulness, sleep hygiene, and adequate rest lower counter‑regulatory hormone surges.
• Medication adherence – set alarms, use pillboxes, and regularly review dosing with a clinician.

Living with Hyperglycemia (high blood sugar)

Effective day‑to‑day control reduces the risk of complications and improves quality of life.

Practical Tips

• Monitor glucose regularly – follow your provider’s recommendation (e.g., fasting, pre‑meal, post‑meal, bedtime). Use CGM if available.
• Keep a log – record readings, meals, activity, stress, and medication changes. Patterns help refine therapy.
• Hydrate – water assists kidneys in flushing excess glucose.
• Plan meals – aim for consistent carbohydrate intake; use the “plate method” (½ non‑starchy veg, ¼ protein, ¼ whole grain or starchy veg).
• Carry fast‑acting carbs (e.g., glucose tablets) for hypoglycemia, which can paradoxically follow overtreatment of hyperglycemia.
• Stay active – even short walks after meals improve post‑prandial glucose.
• Regular check‑ups – HbA1c every 3‑6 months, eye exams, foot exams, and kidney function tests as per guidelines.
• Educate your support network – family or coworkers should know signs of severe hyperglycemia and how to help.

Prevention

While type 1 diabetes cannot be prevented, many cases of type 2 hyperglycemia are modifiable.

• Maintain a healthy weight – a BMI < 25 kg/m² cuts risk by ~50 %.
• Adopt a balanced diet – emphasize whole grains, legumes, fruits, vegetables, lean protein, and healthy fats.
• Engage in regular physical activity – reduces insulin resistance.
• Limit sugary beverages and processed foods – high glycemic load contributes to spikes.
• Screen high‑risk adults – USPSTF recommends diabetes screening for adults 35‑70 years with overweight/obesity; earlier if risk factors present.
• Manage comorbidities – treat hypertension, dyslipidemia, and sleep apnea, which exacerbate insulin resistance.
• Avoid unnecessary glucocorticoids – if required, monitor glucose closely.

Complications

If hyperglycemia persists unchecked, both short‑term and long‑term damage can occur.

Acute complications

• Diabetic ketoacidosis (DKA) – mostly in type 1; characterized by metabolic acidosis, ketonemia, and dehydration.
• Hyperosmolar hyperglycemic state (HHS) – severe hyperglycemia (> 600 mg/dL) with extreme dehydration, more common in older adults with type 2.
• Severe dehydration & electrolyte imbalance – can precipitate renal failure.

Chronic complications (linked to long‑term hyperglycemia)

• Microvascular: retinopathy (leading cause of blindness), nephropathy (chronic kidney disease), peripheral neuropathy (pain, ulceration).
• Macrovascular: accelerated atherosclerosis → coronary artery disease, stroke, peripheral arterial disease.
• Infections: higher incidence of urinary tract, skin, and fungal infections.
• Impaired wound healing – particularly in the feet, raising amputation risk.
• Cognitive decline – studies link chronic hyperglycemia to increased risk of dementia.

According to the CDC, diabetes‑related complications accounted for 6.5 % of all deaths in the United States in 2022.<sup>[3]</sup>

When to Seek Emergency Care

References

1. American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1‑S350.
2. Umpierrez GE, et al. Hyperglycemia: An independent marker of in‑hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2022;107(3):e1305‑e1314.
3. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2023. https://www.cdc.gov/diabetes/data/statistics-report/index.html
4. Mayo Clinic. Hyperglycemia. Updated 2023. https://www.mayoclinic.org
5. World Health Organization. Global report on diabetes. 2021. https://www.who.int

```